| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.606 | 2.531 | 1.798 | 1.740 | 1.956 | 807 | 785 | 950 | 619 | 684 |
| Total Income - EUR | 3.606 | 2.531 | 1.798 | 1.740 | 1.956 | 808 | 785 | 950 | 619 | 684 |
| Total Expenses - EUR | 3.294 | 2.837 | 1.723 | 1.444 | 1.198 | 444 | 544 | 606 | 208 | 752 |
| Gross Profit/Loss - EUR | 312 | -306 | 75 | 296 | 758 | 364 | 242 | 344 | 412 | -69 |
| Net Profit/Loss - EUR | 204 | -383 | 21 | 243 | 700 | 340 | 221 | 320 | 356 | -69 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ivlexima Select S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.341 | 1.511 | 2.550 | 2.334 | 1.313 | 903 | 1.100 | 1.428 | 1.775 | 1.787 |
| Inventories | 1.935 | 1.417 | 2.491 | 2.020 | 1.086 | 663 | 986 | 1.197 | 1.209 | 858 |
| Receivables | 5 | 5 | 0 | 0 | 0 | 0 | 4 | 0 | 12 | 92 |
| Cash | 400 | 89 | 58 | 314 | 227 | 240 | 110 | 231 | 554 | 838 |
| Shareholders Funds | -28 | -410 | -382 | -132 | 570 | 899 | 1.100 | 1.424 | 1.775 | 1.697 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.369 | 1.921 | 2.932 | 2.466 | 743 | 4 | 0 | 4 | 0 | 90 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4782 - 4782" | |||||||||
| CAEN Financial Year |
4782
|
|||||||||
Comments - Ivlexima Select S.r.l.